Hsin-Chih Lai Selected Research

Hsin-Chih Lai Research Topics

Disease

12	Infections 10/2022 - 04/2008
11	Inflammation (Inflammations) 01/2022 - 04/2008
10	Neoplasms (Cancer) 01/2017 - 04/2008
4	Obesity 06/2022 - 06/2015
4	Nasopharyngeal Carcinoma 04/2017 - 03/2011
3	Insulin Resistance 06/2022 - 01/2017
3	Pneumonia (Pneumonitis) 01/2022 - 04/2008
3	Tuberculosis (Tuberculoses) 02/2021 - 08/2012
3	Lung Diseases (Lung Disease) 01/2019 - 01/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2022
2	Congenital Abnormalities (Deformity) 12/2021 - 10/2021
2	Body Weight (Weight, Body) 01/2019 - 02/2017
2	Cross Infection (Nosocomial Infection) 01/2018 - 04/2006
2	Acute Lung Injury 10/2012 - 10/2007
1	Nocardia Infections 10/2022
1	Pediatric Obesity 06/2022
1	Hypoxia (Hypoxemia) 05/2021
1	Tonsillitis 05/2021
1	Mental Disorders (Mental Disorder) 12/2020
1	Epilepsy (Aura) 12/2020
1	Nervous System Diseases (Neurological Disorders) 12/2020
1	Malocclusion (Crossbite) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Neoplasm Metastasis (Metastasis) 06/2018
1	Clostridium Infections 01/2018
1	Disease Progression 01/2018
1	Granuloma 01/2018
1	Carcinogenesis 02/2017
1	Fatigue 01/2017
1	Pulmonary Tuberculosis 11/2016
1	Pain (Aches) 02/2016
1	Fibrosis (Cirrhosis) 10/2015
1	Lung Injury 10/2015
1	Dysbiosis 06/2015
1	Endotoxemia 06/2015
1	Pleural Effusion (Pleural Effusions) 01/2015

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 04/2006
6	InflammasomesIBA 01/2019 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2014
4	ResveratrolIBA 10/2014 - 10/2007
3	LipopolysaccharidesIBA 01/2022 - 10/2007
3	CytokinesIBA 01/2018 - 01/2015
3	EndotoxinsIBA 06/2015 - 10/2007
3	Pharmaceutical PreparationsIBA 12/2014 - 04/2008
2	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 05/2006
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2014
2	PrebioticsIBA 01/2019 - 06/2015
2	Polysaccharides (Glycans)IBA 01/2019 - 06/2015
2	Ethanol (Ethyl Alcohol)IBA 02/2017 - 10/2016
2	AntioxidantsIBA 01/2017 - 10/2014
2	Biological ProductsIBA 01/2017 - 04/2008
2	LipidsIBA 01/2017 - 01/2016
2	PerforinIBA 12/2014 - 04/2014
1	Amikacin (A.M.K)FDA LinkGeneric 10/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2022
1	Linezolid (Zyvox)FDA Link 10/2022
1	Anti-Infective Agents (Microbicides)IBA 10/2022
1	Tigecycline (Tygacil)FDA Link 10/2022
1	TylosinIBA 06/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 05/2021
1	GraphiteIBA 02/2021
1	human MIRN1275 microRNAIBA 12/2020
1	MicroRNAs (MicroRNA)IBA 12/2020
1	16S Ribosomal RNAIBA 01/2020
1	ORALIT (ORS)IBA 01/2020
1	Particulate MatterIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	InterleukinsIBA 01/2019
1	Neomycin FDA LinkGeneric 01/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2018
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	pinicolol BIBA 04/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 02/2017
1	2-Acetylaminofluorene (2 Acetylaminofluorene)IBA 02/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2017
1	Alanine Transaminase (SGPT)IBA 02/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	B7-H1 AntigenIBA 01/2017
1	UreaseIBA 11/2016
1	Transferrin (beta 2 Transferrin)IBA 11/2016
1	Bacterial Proteins (Bacterial Protein)IBA 11/2016
1	EicosanoidsIBA 06/2016
1	CholesterolIBA 01/2016
1	HMGB1 Protein (HMG1)IBA 01/2016
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2015

Therapy/Procedure

4	Therapeutics 10/2022 - 01/2012
3	Orthognathic Surgery 12/2021 - 01/2020
1	Transplantation 01/2022
1	Cannula 01/2022
1	Orthognathic Surgical Procedures 12/2021
1	Immunomodulation 01/2020
1	Hepatectomy 02/2017